Relationship between a history of a suicide attempt and treatment outcomes in patients with depression

Journal of Clinical Psychopharmacology

Volumn 31, Issue 4, 2011, Pages 449-456

  Kim, Sung Wan ^a   Stewart, Robert ^b   Kim, Jae Min ^a   Shin, Il Seon ^a   Yoon, Jin Sang ^a   Jung, Sung Won ^c   Lee, Min Soo ^d   Yim, Hyeon Woo ^e   Jun, Tae Youn ^e  

^a Chonnam National University Medical School   (South Korea)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Keimyung University   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e The Catholic University of Korea   (South Korea)

Author keywords

CRESCEND; depression; remission; suicide; suicide attempts

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; IMIPRAMINE; MILNACIPRAN; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE; TRAZODONE;

ADULT; ANXIETY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DEPRESSION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HOSPITAL; MENTAL PATIENT; MULTICENTER STUDY; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; SOUTH KOREA; SUICIDAL IDEATION; SUICIDE ATTEMPT; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUICIDE, ATTEMPTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960613372     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182217d51     Document Type: Article

References (53)

1. Hendin H. Introduction: suicide and suicide prevention in Asia. In: Hendin H, Phillips MR, Vijayakumar L, et al, ed. Suicide and Suicide Prevention in Asia. Geneva, Switzerland: WHO Press; 2008:1-5.
2. World Health Organization. World Suicide Prevention Day 2008. Geneva, Switzerland: WHO Statement; 2008. Available at: http://www.who.int/mental- health/prevention/suicide/wspd-2008-statement.pdf. Accessed July 1, 2010.
3. Beautrais AL. Suicide in Asia. Crisis. 2006;27:55-57. (Pubitemid 44174143)
4. Korea National Statistical Office. Annual Report on the Cause of Death Statistics of 2009, Daejeon: Korea National Statistical Office; 2010.
5. Korea National Statistical Office. Annual Report on the Cause of Death Statistics of 2006, Daejeon: Korea National Statistical Office; 2007.
6. Mann J. A current perspective on suicide and attempted suicide. Ann Intern Med. 2002;136:302-311.
7. Beautrais AL, Joyce PR, Mulder RT, et al. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. Am J Psychiatry. 1996;153:1009-1014. (Pubitemid 26264700)
8. Blackmore ER, Munce S, Weller I, et al. Psychosocial and clinical correlates of suicidal acts: results from a national population survey. Br J Psychiatry. 2008;192:279-284. (Pubitemid 351692401)
9. Ahrens B, Berghofer A, Wolf T, et al. Suicide attempts, age and duration of illness in recurrent affective disorders. J Affect Disord. 1995;36:43-49. (Pubitemid 26020972)
10. Roy A. Features associated with suicide attempts in depression: a partial replication. J Affect Disord. 1993:27:5-38.
11. Forman EM, Berk MS, Henriques GR, et al. History of multiple suicide attempts as a behavioral marker of severe psychopathology. Am J Psychiatry. 2004;161:437-443. (Pubitemid 38326097)
12. Thompson AH. Younger onset of depression is associated with greater suicidal intent. Soc Psychiatry Psychiatr Epidemiol. 2008;43:538-544.
13. Sokero TP, Melartin TK, Rytsala HJ, et al. Prospective study of risk factors for attempted suicide among patients with DSM-IV major depressive disorder. Br J Psychiatry. 2005;186:314-318. (Pubitemid 40524010)
14. Zisook S, Lesser I, Stewart JW, et al. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry. 2007;164:1539-1546. (Pubitemid 350069733)
15. Oquendo MA, Galfalvy H, Russo S, et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry. 2004;161:1433-1441. (Pubitemid 38989097)
16. Fawcett J, Scheftner W, Fogg L, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry. 1990;147:1189-1194. (Pubitemid 20275373)
17. Oquendo MA, Baca-Garca E, Mann JJ, et al. Issues for DSM-V: suicidal behavior as a separate diagnosis on a separate axis. Am J Psychiatry. 2008;165:1383-1384.
18. Mann JJ, Arango VA, Avenevoli S, et al. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry. 2009;65:556-563.
19. Coryell W, Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry. 2001;158:748-753. (Pubitemid 32429843)
20. Jokinen J, Nordstrom P. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J Affect Disord. 2009;116:117-120.
21. Mann JJ, Currier D, Stanley B, et al. Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol. 2006;9:465-474. (Pubitemid 43979707)
22. Pompili M, Serafini G, Innamorati M, et al. The hypothalamic-pituitary- adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention. Eur Arch Psychiatry Clin Neurosci. 2010;260:583-600.
23. Kim JM, Stewart R, Kim SW, et al. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry. 2007;62:423-428. (Pubitemid 47284032)
24. Brezo J, Klempan T, Turecki G. The genetics of suicide: a critical review of molecular studies. Psychiatr Clin North Am. 2008; 31:179-203. (Pubitemid 351551424)
25. Li D, He L. Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol Psychiatry. 2007;12:47-54. (Pubitemid 44973662)
26. Storosum JG, van Zwieten BJ, van den Brink W, et al. Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry. 2001;158:1271-1275. (Pubitemid 32717702)
27. Nierenberg AA, Trivedi MH, Ritz L, et al. Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines. J Psychiatr Res. 2004;38:583-589. (Pubitemid 39348890)
28. Kim JM, Kim SW, Stewar R, et al. Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study. Hum Psychopharmacol. 2011;26:41-50.
29. Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:956-962.
30. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28-40. (Pubitemid 43050100)
31. Sotsky SM, Glass DR, Shea MT, et al. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry. 1991;148:997-1008.
32. First MB, Spitzer RL, Gibbon M, et al. User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders Research Version (SCID-I). New York, NY: New York State Psychiatric Institute, Biometrics Research; 1996.
33. Hamilton MA. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:10.
34. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: National Institute of Mental Health; 1976.
35. Epping-Jordan J, Ustun TB, Assessment, Classification and Epidemiology Group. The WHODAS II: levelling the playing field for all disorders. WHO Mental Health Bull. 2000;6:5-6.
36. Yi JS, Bae SO, Ahn YM, et al. Validity and reliability of the Korean version of the Hamilton Depression Rating Scale (K-HDRS). J Korean Neuropsychiatr Assoc. 2005;44:456-465.
37. Lee JY, Cho MJ, Kwon JS. Global assessment of functioning scale and social and occupational functioning scale. Korean J Psychopharmacol. 2006;17:122-127.
38. Kim JM, Stewart R, Glozier N, et al. Physical health, depression and cognitive function as correlates of disability in an older Korean population. Int J Geriatr Psychiatry. 2005;20:160-167. (Pubitemid 40277895)
39. Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU Side Effect Rating Scale: a new comprehensive rating scale for psychotropic drugs, and a cross-sectional study of side effects in neuroleptic treated patients. Acta Psychiatr Scand. 1987;S76:1-100. (Pubitemid 17115352)
40. Posner K, Oquendo MA, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;164:1035-1043. (Pubitemid 47121392)
41. Coric V, Feldman HH, Oren DA, et al. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depress Anxiety. 2010;27:417-425.
42. Claassen CA, Trivedi MH, Rush AJ, et al. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. J Affect Disord. 2007;97:77-84. (Pubitemid 44937416)
43. Perroud N, Uher R, Hauser J, et al. History of suicide attempts among patients with depression in the GENDEP project. J Affect Disord. 2010;123:131-137.
44. Kohli MA, Salyakina D, Pfennig A, et al. Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients. Arch Gen Psychiatry. 2010;67:348-359.
45. Pintor L, Torres X, Navarro V, et al. Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with corticotropin releasing factor test. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:463-469.
46. Cheng IC, Liao SC, Lee MB, et al. Predictors of treatment response and length of stay for inpatients with major depression. J Formos Med Assoc. 2007;106:903-910.
47. Oquendo MA, Currier D, Mann JJ, et al. Prospective studies of suicidal behavior in major depressive and bipolar disorders: what is the evidence for predictive risk factors? Acta Psychiatr Scand. 2006;114:151-158.
48. Zisook S, Trivedi MH, Warden D, et al. Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. J Affect Disord. 2009;117:63-73.
49. Marangell LB, Bauer MS, Dennehy EB, et al. Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years. Bipolar Disord. 2006;8:566-575. (Pubitemid 44567139)
50. Stein MB, Yehuda R, Koverola C, et al. Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol Psychiatry. 1997;42:680-686. (Pubitemid 27444502)
51. Ribeiro SC, Tandon R, Grunhaus L, et al. The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry. 1993;150:1618-1629. (Pubitemid 23325942)
52. Fu Q, Heath AC, Bucholz KK, et al. A twin study of genetic and environmental influences on suicidality in men. Psychol Med. 2002;32:11-24. (Pubitemid 33150500)
53. Powell J, Geddes J, Deeks J, et al. Suicide in psychiatric hospital in-patients: risk factors and their predictive power. Br J Psychiatry. 2000;176:266-272. (Pubitemid 30179847)